More US investors point their attention towards Novo Nordisk
Throughout 2023, private investors in the US have increased their focus on the Novo Nordisk stock, according to fresh data from Vanda Research, which holds the largest database on trading among private US investors, reports Danish business daily Børsen.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.